Physician profile
Madison E Miller
NPI 1518577980
$1,290.88
in general payments reported to CMS, 2019-2025
18 companies · $253 in 2025
The $253 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $181 · 2022: $366 · 2023: $342 · 2024: $149 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $744.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $212.32 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $134.94 | 2022-2025 | Caplyta |
| Ironshore Pharmaceuticals INC. | $130.11 | 2021-2023 | Jornay Pm |
| Janssen Pharmaceuticals, INC | $120.68 | 2021-2024 | Spravato |
| Otsuka America Pharmaceutical, INC. | $112.81 | 2022-2025 | Rexulti, Abilify Asimtufii |
| Vanda Pharmaceuticals INC. | $94.58 | 2021-2025 | Fanapt |
| Corium, LLC | $83.17 | 2022-2025 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $74.96 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $69.12 | 2022-2023 | Qelbree |
| Alkermes, INC. | $62.90 | 2022-2024 | Lybalvi, Aristada |
| Axsome Therapeutics, INC. | $43.07 | 2023 | Auvelity, Sunosi |
| Teva Pharmaceuticals USA, INC. | $37.32 | 2025 | Austedo Xr |
| Neurocrine Biosciences, INC. | $36.93 | 2022-2025 | |
| Avanir Pharmaceuticals, INC. | $19.60 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $16.94 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $15.05 | 2021 | |
| Neos Therapeutics, Lp | $14.03 | 2022 | |
| Tris Pharma INC | $12.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madison Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.